Exclusion criteria included low hemoglobin concentration (<8 g/l for men and <7 g/l for women), unwillingness to give consent, or absence of obstructive CAD, defined as any stenosis $70% or left main stenosis $50% (12) . All patients were contacted by phone up to 24 months after the index hospitalization to ascertain the incidence of major adverse cardiac and cerebrovascular events (MACCE). 
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(Supplemental Appendix). Briefly, male Wistar rats (250 to 300 g) underwent permanent ligation of the left anterior descending artery, sham thoracotomy, or anesthesia without surgery (AMI/sham/healthy groups). The combination of isoflurane for anesthesia, pentobarbital for euthanasia, and organ harvesting during anesthesia rather than posteuthanasia has been shown to minimally perturb the rodent metabolome (13) .
H u m a n a r t e r i a l t i s s u e a n d p l a s m a . We then used deep-learning predictor selection and risk stratification methods (data-driven grouping
[DDg] and statistically-weighted voting grouping
[SWVg], respectively) (Supplemental Figure 3) . This model, which we had previously developed and validated (15) (16) (17) (18) (19) (20) , is described in the Supplemental Appendix. Briefly, at the first step of the method, we apply the DDg method to identify cut-off values (intensities) of individual prognostic variables (i.e., ceramides) that optimally separate patients into low-and high-risk MACCE groups, In the second step, the SWVg method utilizes the 1D-DDg-defined ceramide risk categories for each patient and combines ceramides in a stepwise multivariable fashion to produce a synergistic multiceramide signature.
To define a robust prognostic signature, we only included component ceramides that were statistically Thus, we conclude that high-risk patients have an overexpression of the selected plasma ceramides on days 1 and 2; however, day 2 ceramides more accurately identified patients who were at high-risk of MACCE.
IDENTIFICATION OF THE MULTICERAMIDE PROGNOSTIC
SIGNATURE. Supplemental Figure 3 shows the workflow of the discovery and validation analyses.
Supplemental Table 3 shows that 20 ceramides measured at day 2 were significant for MACCE-free survival (false discovery rate <0.05). Notably, for 18 of the 20 ceramides selected in the discovery cohort, the 1D-DDg-defined cut-off values better stratified patients into low-and high-risk patient groups compared with the GRACE score. Supplemental Table 3 summarizes the univariate 1D-DDg and multivariate SWVg models used in the training cohort. As shown in Figure 1A Table 3 ). By comparing the MACCEfree survival rates of the GRACE score-defined lowand high-risk groups in the discovery and validation cohorts, we see that the GRACE score had the poorest reproducibility in predicting actual survival rates of both the low-and high-risk groups ( Figure 1A) . In contrast, low-and high-risk groups defined by an individual ceramide predictor yielded more similar MACCE-free survival rates in the discovery and validation cohorts, especially among the high-risk group de Carvalho et al.
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Ceramides in AMI
A P R I L 2 0 1 8 : 1 6 3 -7 5 Mitochondrial dysfunction is a key event mediating cell death in ischemia-reperfusion injury, the insult leading to the many long-term sequelae in AMI, and ceramides are strongly implicated in mitochondrialinduced apoptotic cell death (6, 27) . Endogenous ceramides, generated from either de novo synthesis or sphingomyelinase activation in response to diverse cellular stress stimuli such as hypoxia, ischemia-reperfusion, chemotherapy, or g-irradiation,
mediate mitochondrial cytochrome C release and apoptosis of cardiomyocytes (27) . Consistent with the pattern of increased ceramide production in our rat model of AMI, other studies have shown an increase in myocardial ceramide levels during ischemic-reperfusion injury with corresponding down-regulation of ceramidase activity (28,29) and p < 0.05 was considered statistically significant. *Design: 1 ¼ protective effect; 2 ¼ harmful effect. †Number of ceramides in the signature.
1D-DDg ¼ 1-dimensional data-driven grouping; SWVg ¼ statistically-weighted voting grouping; other abbreviations as in Table 2 .
dramatic reciprocal up-regulation of SPT (30) and sphingomyelinase (31) . Serine palmitoyl transferase is a key rate-limiting enzyme catalyzing the first step in the de novo synthesis of ceramides (32) . Interestingly, the inhibition of SPT with myriocin protects cardiomyocytes from lipotoxic injury, suggesting a potential role for therapeutic ablation of the de novo ceramide pathway to minimize myocardial injury (33) .
SMases hydrolyses sphingomyelin, releasing phosphocholines and ceramides. Ischemia-reperfusion leads to an elevation of SMase activities and subsequent activation of TNF-a mediated apoptosis (34) .
Meanwhile, the blockade of SMase activity with Nacetylcysteine abrogates TNF-a-induced apoptosis de Carvalho et al.
